Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-12-250764
Filing Date
2012-05-29
Accepted
2012-05-29 13:10:45
Documents
14
Period of Report
2012-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d353592d6k.htm 6-K 12429
2 EXHIBIT 99.1 d353592dex991.htm EX-99.1 7799
3 EXHIBIT 99.2 d353592dex992.htm EX-99.2 527437
4 EXHIBIT 99.3 d353592dex993.htm EX-99.3 37895
5 EXHIBIT 99.4 d353592dex994.htm EX-99.4 6520
6 GRAPHIC g353592ex99_3pg01a.jpg GRAPHIC 7012
7 GRAPHIC g353592ex99_3pg01b.jpg GRAPHIC 2892
8 GRAPHIC g353592ex99_3pg01c.jpg GRAPHIC 4593
9 GRAPHIC g353592ex99_3pg01d.jpg GRAPHIC 4741
10 GRAPHIC g353592ex99_3pg01e.jpg GRAPHIC 4258
11 GRAPHIC g353592g11e83.jpg GRAPHIC 44592
12 GRAPHIC g353592g84m75.jpg GRAPHIC 10470
13 GRAPHIC g353592page001.jpg GRAPHIC 164234
14 GRAPHIC g353592page002.jpg GRAPHIC 160333
  Complete submission text file 0001193125-12-250764.txt   1149910
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 12873463
SIC: 2834 Pharmaceutical Preparations